Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

US to Spend $3.2 Billion on COVID Treatments Research

06/17/2021 | 02:09pm EDT


ę MT Newswires 2021
All news about PFIZER, INC.
03:39pALPHABET : Pfizer to require U.S. workers receive COVID-19 vaccine or regular te..
RE
01:26pPFIZER : UK to roll out COVID-19 vaccines to 16 and 17-year-olds
AQ
11:19aPFIZER : Releases Positive Results From Trial of Ritlecitinib in Patients With A..
MT
10:58aGLOBAL MARKETS LIVE : Novartis, Apple, Commerzbank, Amgen, Lyft...
10:23aPFIZER : South Africa quickens vaccine drive, gets more doses from US
AQ
09:32aPFIZER : Thinking about trading options or stock in Activision Blizzard, BioNTec..
PR
09:24aToday on Wall Street: Is the economic recovery still on track?
07:28aMARKET CHATTER : Thonburi Healthcare Faces Regulatory Pressure on Purported Vacc..
MT
07:00aPRESS RELEASE : BioNTech Completes Acquisition of Kite's Neoantigen TCR Cell The..
DJ
06:46aPFIZER : Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitin..
BU
More news
Financials (USD)
Sales 2021 79 586 M - -
Net income 2021 18 722 M - -
Net Debt 2021 26 885 M - -
P/E ratio 2021 13,3x
Yield 2021 3,45%
Capitalization 256 B 256 B -
EV / Sales 2021 3,55x
EV / Sales 2022 4,29x
Nbr of Employees 78 500
Free-Float 59,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Last Close Price 45,68 $
Average target price 43,82 $
Spread / Average Target -4,07%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.24.10%255 703
JOHNSON & JOHNSON10.81%459 079
ROCHE HOLDING AG14.16%340 492
ELI LILLY AND COMPANY51.62%232 701
NOVARTIS AG-0.20%224 638
NOVO NORDISK A/S36.67%213 138